| Identification | Back Directory | [Name]
m-PEG9-COOH | [CAS]
2576495-35-5 | [Synonyms]
m-PEG9-COOH
4,7,10,13,16,19,22,25,28-Nonaoxanonacosanoic acid
2,5,8,11,14,17,20,23,26-Nonaoxanonacosan-29-oic acid | [Molecular Formula]
C20H40O11 | [MDL Number]
MFCD27977514 | [MOL File]
2576495-35-5.mol | [Molecular Weight]
456.52 |
| Chemical Properties | Back Directory | [Boiling point ]
536.3±50.0 °C(Predicted) | [density ]
1.111±0.06 g/cm3(Predicted) | [storage temp. ]
2-8°C, sealed storage, away from moisture | [form ]
Liquid | [pka]
4.28±0.10(Predicted) | [color ]
Colorless to light yellow | [InChI]
InChI=1S/C20H40O11/c1-23-4-5-25-8-9-27-12-13-29-16-17-31-19-18-30-15-14-28-11-10-26-7-6-24-3-2-20(21)22/h2-19H2,1H3,(H,21,22) | [InChIKey]
HVDSDOIAPZITDA-UHFFFAOYSA-N | [SMILES]
C(O)(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOC |
| Hazard Information | Back Directory | [Uses]
m-PEG9-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. | [Biological Activity]
m-PEG9-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1].
PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1]. | [IC 50]
PEGs | [References]
[1]. An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 |
|
|